Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
Go back to Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million| (NASDAQ: JUNS) | Delayed: 3.28 +0.02 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.26 | 52 Week High | $ | |||
| Open | $3.36 | 52 Week Low | $ | |||
| Day High | $3.61 | P/E | N/A | |||
| Day Low | $3.27 | EPS | $ | |||
| Volume | 25,002 | |||||
| (NASDAQ: JUNS) | Delayed: 3.28 +0.02 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.26 | 52 Week High | $ | |||
| Open | $3.36 | 52 Week Low | $ | |||
| Day High | $3.61 | P/E | N/A | |||
| Day Low | $3.27 | EPS | $ | |||
| Volume | 25,002 | |||||

